Studies reported at AAIC 2019 have demonstrated the links between lifestyle factors and dementia; this information could provide new insight into the best ways to alleviate the likelihood of developing the disease.
Browsing: Cognitive/neurodegenerative disorders
Androgen deprivation therapy has been associated with a higher likelihood of developing dementia in men with prostate cancer when compared with individuals who are not exposed to the treatment.
Recent research at EAN 2019 suggests that the loss of ability to find one’s way, to keep track of time and to create and retrieve memories may all be hallmarks of Alzheimer’s disease.
A recently published study has suggested that certain anticholinergic medications, such as antidepressants and epilepsy drugs, may increase the risks of dementia later in life.
Nilvadipine has been demonstrated to increase blood flow to the hippocampus among people with Alzheimer’s disease, according to a recent study.
Researchers have found that the sleep history and pattern of older men and women may predict the accumulation of proteins associated with Alzheimer’s disease.
In a revolutionary approach, Cognetivity (London, UK) have created a new test for detecting dementia and Alzheimer’s disease by focusing on image cognition and the brain’s ability to analyze visual information.
Couldn’t attend the Alzheimer’s Society ‘United Against Dementia Annual Conference’ 2019? Our Editor, Sharon Salt, provides her key highlights from the two-day event here.
In a recent study, researchers have discovered a possible link between high LDL cholesterol and early-onset Alzheimer’s disease.
In this interview, Anders Björklund speaks to us about how we might overcome the current limitations of using stem cell therapies for Parkinson’s disease.